Toxicity studies of a bioactive protein with antithrombotic–thrombolytic activity, DLBS1033

References

• Arjomand H, Cohen M, Ezekowitz MD. (2004). Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease. J Invasive Cardiol 16:271–278
   PubMedGoogle Scholar
• Awtry EH, Loscalzo J. (2000). Aspirin. Circulation 101:1206–1218
   PubMed Web of Science ®Google Scholar
• Bates SM, Greer IA, Pabinger I, et al. (2008). Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based (Clinical Practice Guidelines 8th Edition). Chest 133:844S–886S
   PubMed Web of Science ®Google Scholar
• Buresly K, Eisenberg MJ, Zhang X, Pilote L. (2005). Bleeding complications associated with combinations of aspirin, thienopyridine derivatives and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med 165:784–789
   PubMed Web of Science ®Google Scholar
• CAPRIE Steering Committee. (1996). A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339
   PubMed Web of Science ®Google Scholar
• Chinese Acute Stroke Trial (CAST) Collaborative Group. (1997). A randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet 349:1641–1649
   PubMed Web of Science ®Google Scholar
• Delaney JA, Opatrny L, Brophy JM, Suissa S. (2007). Drug--drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 177:347–351
   PubMed Web of Science ®Google Scholar
• Dentali F, Douketis JD, Lim W, Crowther M. (2007). Combined aspirin-oral anticoagulant therapy compared with oral anticoagulant therapy alone among patients at risk for cardiovascular disease: a meta-analysis of randomized trials. Arch Intern Med 167:117–124
   PubMed Web of Science ®Google Scholar
• Fisher M, Loscalzo J. (2011). The perils of combination antithrombotic therapy and potential resolutions. Circulation 123:232–235
   PubMed Web of Science ®Google Scholar
• Gurbel PA, Tantry US. (2010). Combination antithrombotic therapies. Circulation 121:569–583
   PubMed Web of Science ®Google Scholar
• Hankey GJ, Sudlow CL, Dunbabin DW. (2000). Thienopyridine derivatives (ticlodipine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients. Cochrane Database Syst Rev 2:CD001246 . Available from: http://www.ncbi.nlm.nih.gov/pubmed/10796426
   PubMedGoogle Scholar
• Hernandez-Diaz S, Garcia RLA. (2006). Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med 4:22 . Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590044/
   PubMed Web of Science ®Google Scholar
• International Stroke Trial (IST) Collaborative Group. (1997). A randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet 349:1569–1581
   PubMedGoogle Scholar
• James AH. (2009). Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol 29:326–331
   PubMed Web of Science ®Google Scholar
• Kam PCA, Nethery CM. (2003). The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anesthesia 58:28–35
   PubMed Web of Science ®Google Scholar
• Kurnia F, Tjandrawinata RR. (2011). Bioactive protein fraction DLBS1033 exerts its positive pleiotropic effects in the vascular cells via down regulation of gene expression. Medicinus 24:18–24
   Google Scholar
• Laurence DR, Bacharach AL. (Eds.). (1964). Evaluation of drug activities: pharmacometrics, vol. 1. London: Academic, p. 897
   Google Scholar
• Mitruka BM, Rawnsley HW. (1980). Clinical biochemical and hematological reference values in normal experimental animals and normal humans, 2nd. London: Masson, p. 160
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). (1998). Repeated dose 90-day oral toxicity study in rodents. Test Guideline no. 408, OECD Guidelines for the testing of chemicals. Paris: OECD. Available on the OECD library public website for test guidelines at: www.oecd-library.org. Accessed on April 23, 2010
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). (2001a). Acute oral toxicity: acute toxic class method. Test Guideline no. 423, OECD Guidelines for the testing of chemicals. Paris: OECD. Available on the OECD library public website for test guidelines at: www.oecd-library.org. Accessed on April 23, 2010
   Google Scholar
• Organization for Economic Co-operation and Development (OECD). (2001b). Prenatal developmental toxicity study. Test Guideline no. 414, OECD Guidelines for the testing of chemicals. Paris: OECD. Available on the OECD library public website for test guidelines at: www.oecd-library.org. Accessed on April 23, 2010
   Google Scholar
• Patrono C. (1997). Unstable coronary artery disease: need for long-term antithrombotic treatment? Aspirin alone may not be the ideal antithrombotic strategy, but that’s what we have adequate trial data for. Cardiovasc Res 33:295–296
   PubMed Web of Science ®Google Scholar
• Sajuthi D, Suhartono MT, Tjandrawinata RR. (2011). Provision of security studies DLBS1033 bioactive protein fractions on long-tailed macaque (Macaca fascicularis). [in Indonesian]. Medicinus 24:15–21
   Google Scholar
• The ACTIVE Investigators. (2009). Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 360:2066–2078
   PubMed Web of Science ®Google Scholar
• Thompson EB. (1990). Drug bioscreening, fundamentals of drug evaluation techniques in pharmacology. 1st ed. New York: Graceway Publishing Co., 91--93
   Google Scholar
• Trisina J, Sunardi F, Suhartono MT, Tjandarawinata RR. (2011). DLBS1033: a protein extract from Lumbricus rubellus, possesses antithrombotic and thrombolytic activities. J Biomed Biotech 11:519–652
   Google Scholar
• World Health Organization (WHO). (1978). Principles and methods for evaluating the toxicity of chemicals. Geneva: WHO. Available on the WHO library at: www.who.int/library. Accessed on April 23, 2010
   Google Scholar
• Yusuf S, Zhao F, Mehta SR. (2001). Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J M 345:494–502
   PubMed Web of Science ®Google Scholar